search
Back to results

Effect of the Compound Extracted From Azadirachta Indica Leaves in the Treatment of Arsenical Keratosis

Primary Purpose

Keratotic Nodular Size

Status
Unknown status
Phase
Not Applicable
Locations
Bangladesh
Study Type
Interventional
Intervention
Azadirachta indica leaves extract containing ointment intervention.
Sponsored by
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Keratotic Nodular Size

Eligibility Criteria

19 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. 19 to 65 years of age
  2. Male and female both were included
  3. Presence of palmar arsenical keratosis which nature was moderate to severe (2 to >5)
  4. Used water at least more than 6 months which was contaminated with arsenic (>50 µg/L) especially for drinking purpose
  5. Any drug like topical application did not received by the patient for at least last three month

Exclusion Criteria:

  1. <19 and >65 years of age
  2. Pregnant and breast feeding mother
  3. Accept any treatment at least last three months for arsenicosis
  4. Any type of skin disease like drug allergy, atopic dermatitis, psoriasis, eczema and other keratosis
  5. Various systemic disease like diabetes mellitus, hepatitis, rheumatoid arthritis and others that affected the skin

Sites / Locations

  • Muradnagar UpazillaRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Azadirachta indica leaves extract containing ointment intervention.

Arm Description

Azadirachta indica leaves extract containing ointment will be used twice daily for 12 weeks

Outcomes

Primary Outcome Measures

Keratotic nodular size
Lesion size will be measured by slide calipers

Secondary Outcome Measures

Full Information

First Posted
December 23, 2020
Last Updated
January 7, 2021
Sponsor
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
search

1. Study Identification

Unique Protocol Identification Number
NCT04686474
Brief Title
Effect of the Compound Extracted From Azadirachta Indica Leaves in the Treatment of Arsenical Keratosis
Official Title
Effect of the Compound Extracted From Azadirachta Indica Leaves in the Treatment of Arsenical Keratosis
Study Type
Interventional

2. Study Status

Record Verification Date
January 2021
Overall Recruitment Status
Unknown status
Study Start Date
October 20, 2019 (Actual)
Primary Completion Date
January 20, 2021 (Anticipated)
Study Completion Date
February 20, 2021 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Prepare an ointment from Azadirachta indica leaves extract and its apply on palmer arsenical keratosis patient, for 12 weeks. After intervention, effect of the ointment will be observed by measuring the nodule (before and after apply the ointment)
Detailed Description
Arsenicosis or arsenic toxicity caused by prolong ingestion of contaminated groundwater by inorganic arsenic (more than 0.05 mg/liter). It is the severest natural calamity widespread specially in Bangladesh where 61 districts out of 64 are affected. The commonest and earliest feature of arsenicosis is skin involvement like keratosis, melanosis and skin carcinoma. Keratosis of the palm and soles reduce the working ability of the patient's and affect their socio-economic condition. There is no specific treatment for keratosis. Short-term improvement may occur by using some topical keratolytic like salicylic acid, propylene glycol, eating some dietary supplementation like vitamin A, C, E, zinc, folic acid and foodstuffs like corn, spinach but symptoms recure after stoppage of these treatments. Also, these treatments require longer duration which ultimately affects patient adherence. Azadirachta indica leaves contain flavonoids, quercetin, azadirachtin, nimbin, steroids, alkaloids, phenolic compounds and other biologically active compounds that have anti-proliferative, anticarcinogenic, antioxidative and immunostimulant effects. For this reason, a study named "Effect of ethanol extract of leaves of Azadirachta indica on palmer arsenical keratosis: A single-blind trial" was done in the Department of Pharmacology, Bangabandhu Sheikh Mujib Medical University, which was found effective . So, the purpose of this study is to evaluate the effectiveness of the identified compound on moderate to severe arsenical keratosis which will be isolated from A. indica leaves extract. After IRB clearance, 35 patients with moderate to severe arsenical keratosis will be collected based on inclusion and exclusion criteria from the arsenic affected area, located at Kamalla Union of Muradnagar Upazilla, Comilla. The study will be quasi-experimental study. Included patients will be informed about the purpose of this study, as well as harmful and beneficial effects. Informed written consent, detail history, clinical examination, photographs of the palm and sole and nail samples will be collected before starting recruitment to confirm arsenicosis. For identification of isolated compounds present in the A. indica leaves, thin layer chromatography, nuclear magnetic resonance, and infrared spectrometry will be done. Cytotoxic effects of the A. indica leaves extract will be assessed by using brine shrimp bioassay. The ointment will be prepared from A. indica leaves extract and supplied to the patient at an interval of 2 weeks. Each patient will be advised to apply the ointment, with a clean fingertip by rubbing gently in the morning and night for 12 weeks. Regular monitoring will be done through phone calls and during a follow-up visit at the field level, about improvement and side effects of the ointment. Clinical improvement will be assessed by measuring the keratotic nodular size with the help of slide calipers. Statistical analysis will be done by paired t-test.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Keratotic Nodular Size

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
35 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Azadirachta indica leaves extract containing ointment intervention.
Arm Type
Experimental
Arm Description
Azadirachta indica leaves extract containing ointment will be used twice daily for 12 weeks
Intervention Type
Drug
Intervention Name(s)
Azadirachta indica leaves extract containing ointment intervention.
Intervention Description
Azadirachta indica leaves extract containing ointment, white petroleum, bee wax, stearyl alcohol
Primary Outcome Measure Information:
Title
Keratotic nodular size
Description
Lesion size will be measured by slide calipers
Time Frame
12 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
19 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: 19 to 65 years of age Male and female both were included Presence of palmar arsenical keratosis which nature was moderate to severe (2 to >5) Used water at least more than 6 months which was contaminated with arsenic (>50 µg/L) especially for drinking purpose Any drug like topical application did not received by the patient for at least last three month Exclusion Criteria: <19 and >65 years of age Pregnant and breast feeding mother Accept any treatment at least last three months for arsenicosis Any type of skin disease like drug allergy, atopic dermatitis, psoriasis, eczema and other keratosis Various systemic disease like diabetes mellitus, hepatitis, rheumatoid arthritis and others that affected the skin
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Israt Zahan Zarin, MBBS
Phone
01729181559
Email
drisratzahan34@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Bangladesh Muradnagar Upazilla.Comilla
Organizational Affiliation
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Official's Role
Principal Investigator
Facility Information:
Facility Name
Muradnagar Upazilla
City
Comilla
Country
Bangladesh
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Israt Zahan Zarin, MBBS
Phone
01729181559
Email
drisratzahan34@gmail.com

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Effect of the Compound Extracted From Azadirachta Indica Leaves in the Treatment of Arsenical Keratosis

We'll reach out to this number within 24 hrs